Effects of Ureaplasma parvum lipoprotein multiple-banded antigen on pregnancy outcome in mice

Journal of Reproductive Immunology

Volumn 100, Issue 2, 2013, Pages 118-127

  Uchida, Kaoru ^a,g   Nakahira, Kumiko ^a   Mimura, Kazuya ^a,b   Shimizu, Takashi ^c   De Seta, Francesco ^d   Wakimoto, Tetsu ^a,b   Kawai, Yasuhiro ^a   Nomiyama, Makoto ^e   Kuwano, Koichi ^f   Guaschino, Secondo ^d,h   Yanagihara, Itaru ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d UNIVERSITY OF TRIESTE   (Italy)

^e National Saga Hospital   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYUSHU NUTRITION WELFARE UNIVERSITY   (Japan)

^h UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Multiple banded antigen; NF B; Preterm; Toll like receptor 2; Ureaplasma parvum

Indexed keywords

ALPHA CHEMOKINE; BACTERIAL ANTIGEN; CHLORMETHINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P35; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN; LPS INDUCED CXC CHEMOKINE; LUCIFERASE; MACROPHAGE INFLAMMATORY PROTEIN 2; MULTIPLE BANDED ANTIGEN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; C3H/HE MOUSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM MACROPHAGE; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UREAPLASMA PARVUM; UTERUS;

ANALYSIS OF VARIANCE; ANOVA; CAM; CHORIOAMNIONITIS; DIMETHYL SULFOXIDE; DMSO; GAPDH; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; H&E; HEMATOXYLIN AND EOSIN; IL; INDUCIBLE NITRIC OXIDE SYNTHASE; INOS; INTERLEUKIN; INTRAUTERINE FETAL DEATH; IUFD; KC; KERATINOCYTE-DERIVED CHEMOKINE; LIX; LPS-INDUCED CXC CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MBA; MIP2; MRF; MULTIPLE-BANDED ANTIGEN; MULTIPLE-BANDED ANTIGEN RICH FRACTION; NF-ΚB; NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS; PBS; PHOSPHATE BUFFERED SALINE; PRETERM; RECOMBINANT MBA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RMBA; RT-PCR; TLR; TNF; TOLL-LIKE RECEPTOR; TOLL-LIKE RECEPTOR 2; TRITON X-114; TUMOR NECROSIS FACTOR; TX-114; U. PARVUM; UREAPLASMA PARVUM;

ANIMALS; BACTERIAL PROTEINS; CELL LINE, TUMOR; CHORIOAMNIONITIS; FEMALE; FETAL DEATH; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEUTROPHILS; NF-KAPPA B; PEPTIDE FRAGMENTS; PLACENTA; PREGNANCY; PREMATURE BIRTH; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; UREAPLASMA; UREAPLASMA INFECTIONS; VIRULENCE FACTORS;

EID: 84889086266     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.10.001     Document Type: Article

References (40)

1. Athanassakis I., Aifantis I., Ranella A., Giouremou K., Vassiliadis S. Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice. Nitric Oxide 1999, 3:216-224.
2. Breugelmans M., Vancutsem E., Naessens A., Laubach M., Foulon W. Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study. Acta Obstet. Gynecol. Scand. 2010, 89:256-260.
3. Burdet J., Zotta E., Cella M., Franchi A.M., Ibarra C. Role of nitric oxide in shiga toxin-2-induced premature delivery of dead fetuses in rats. PLoS ONE 2010, 5:e15127.
4. Cassell G.H., Waites K.B., Watson H.L., Crouse D.T., Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin. Microbiol. Rev. 1993, 6:69-87.
5. Cella M., Farina M.G., Dominguez Rubio A.P., Di Girolamo G., Ribeiro M.L., Franchi A.M. Dual effect of nitric oxide on uterine prostaglandin synthesis in a murine model of preterm labour. Br. J. Pharmacol. 2010, 161:844-855.
6. Constantin D., Cordenier A., Robinson K., Ala'aldeen D.A., Murphy S. Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase. J. Neurochem. 2004, 89:1166-1174.
7. Dunwoodie S.L. The role of hypoxia in development of the mammalian embryo. Dev. Cell 2009, 17:755-773.
8. Garcia J., Lemercier B., Roman-Roman S., Rawadi G. A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J. Biol. Chem. 1998, 273:34391-34398.
9. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N. Engl. J. Med. 2000, 342:1500-1507.
10. Goncalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:3-13.
11. Harada K., Tanaka H., Komori S., Tsuji Y., Nagata K., Tsutsui H., et al. Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses. Microbiol. Immunol. 2008, 52:297-304.
12. He J., You X., Zeng Y., Yu M., Zuo L., Wu Y. Mycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway. Clin. Vaccine Immunol. 2009, 16:1750-1757.
13. Into T., Kiura K., Yasuda M., Kataoka H., Inoue N., Hasebe A., et al. Stimulation of human toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappaB activation. Cell. Microbiol. 2004, 6:187-199.
14. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
15. Kataoka S., Yamada T., Chou K., Nishida R., Morikawa M., Minami M., et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J. Clin. Microbiol. 2006, 44:51-55.
16. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat. Immunol. 2010, 11:373-384.
17. Kawane K., Tanaka H., Kitahara Y., Shimaoka S., Nagata S. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19432-19437.
18. Kimizuka Y., Kimura S., Saga T., Ishii M., Hasegawa N., Betsuyaku T., et al. Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model. Infect. Immun. 2012, 80:1121-1127.
19. Kundsin R.B., Leviton A., Allred E.N., Poulin S.A. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet. Gynecol. 1996, 87:122-127.
20. Larsen B., Hwang J. Mycoplasma, ureaplasma, and adverse pregnancy outcomes: a fresh look. Infect. Dis. Obstet. Gynecol. 2010, 10.1155/2010/521921.
21. Li Y.H., Yan Z.Q., Jensen J.S., Tullus K., Brauner A. Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages. Infect. Immun. 2000, 68:7087-7093.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Mohammad G., Mairaj Siddiquei M., Imtiaz Nawaz M., Abu El-Asrar A.M. The ERK1/2 inhibitor U0126 attenuates diabetes-induced upregulation of MMP-9 and biomarkers of inflammation in the retina. J. Diabetes Res. 2013, 2013:658548.
24. Namba F., Hasegawa T., Nakayama M., Hamanaka T., Yamashita T., Nakahira K., et al. Placental features of chorioamnionitis colonized with Ureaplasma species in preterm delivery. Pediatr. Res. 2010, 67:166-172.
25. Ogando D.G., Paz D., Cella M., Franchi A.M. The fundamental role of increased production of nitric oxide in lipopolysaccharide-induced embryonic resorption in mice. Reproduction 2003, 125:95-110.
26. Okusawa T., Fujita M., Nakamura J., Into T., Yasuda M., Yoshimura A., et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect. Immun. 2004, 72:1657-1665.
27. Ramesh G., Zhang B., Uematsu S., Akira S., Reeves W.B. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice. Am. J. Physiol. Renal Physiol. 2007, 293:F325-F332.
28. Shimizu T., Kida Y., Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappaB through TLR1, TLR2, and TLR6. J. Immunol. 2005, 175:4641-4646.
29. Shimizu T., Kida Y., Kuwano K. Ureaplasma parvum lipoproteins, including MB antigen, activate NF-{kappa}B through TLR1, TLR2 and TLR6. Microbiology 2008, 154:1318-1325.
30. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M., et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 2000, 164:554-557.
31. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
32. Uno K., Kato K., Atsumi T., Suzuki T., Yoshitake J., Morita H., et al. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1004-G1012.
33. Waites K., Talkington D. New developments in human diseases due to mycoplasmas. Mycoplasmas Molecular Biology Pathogenicity and Strategies for Control 2005, 289-354. Horizon Bioscience, Norfolk, UK. A. Blanchard, G. Browning (Eds.).
34. Waites K.B., Katz B., Schelonka R.L. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 2005, 18:757-789.
35. Waites K.B., Schelonka R.L., Xiao L., Grigsby P.L., Novy M.J. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin. Fetal Neonatal Med. 2009, 14:190-199.
36. Watson H.L., Blalock D.K., Cassell G.H. Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes. Infect. Immun. 1990, 58:3679-3688.
37. Yamamoto M., Kikuchi H., Ohta M., Kawabata T., Hiramatsu Y., Kondo K., et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 2008, 68:9754-9762.
38. Yoon B.H., Romero R., Lim J.H., Shim S.S., Hong J.S., Shim J.Y., et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am. J. Obstet. Gynecol. 2003, 189:919-924.
39. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008, (chapter 14, Unit 14.11).
40. Zheng X., Teng L.J., Watson H.L., Glass J.I., Blanchard A., Cassell G.H. Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect. Immun. 1995, 63:891-898.